Feature Channels: AIDS and HIV

Filters close
Newswise: Wistar Scientists Discover Link Between Leaky Gut and 
Accelerated Biological Aging
Released: 23-Feb-2024 10:05 AM EST
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
Wistar Institute

Wistar Institute’s Dr. Mohamed Abdel-Mohsen has demonstrated a connection between viral damage to the gut and premature biological aging.

Newswise: Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
20-Feb-2024 12:05 PM EST
Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
University of California, Los Angeles (UCLA), Health Sciences

A UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans, a group that historically has had low use of the medication.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 2:05 AM EST
Researchers are using RNA in a new approach to fight HIV
University of Waterloo

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.

Newswise: Colonial legacies fuel unfair practices in African research
Released: 19-Feb-2024 10:05 PM EST
Colonial legacies fuel unfair practices in African research
SciDev.Net

Higher income countries must move away from unfair data practices that undermine African researchers, writes Nicki Tiffin.

   
19-Feb-2024 5:00 AM EST
Droughts may trigger HIV transmission increase among women in rural sub-Saharan Africa, study finds
University of Bristol

Droughts have the potential to increase the spread of HIV for women living in rural parts of Africa, researchers at the University of Bristol have found.

Newswise: Inequities in HIV testing, diagnosis and care for people with intellectual and developmental disabilities
Released: 15-Feb-2024 2:00 PM EST
Inequities in HIV testing, diagnosis and care for people with intellectual and developmental disabilities
Michigan Medicine - University of Michigan

There is a large discrepancy in HIV care and education for those with intellectual disabilities that results in an increase in HIV in the population.

13-Feb-2024 2:05 PM EST
Study Reveals Accelerated Aging in Women Living With HIV
Rutgers University-New Brunswick

Women with HIV experience accelerated DNA aging, a phenomenon that can lead to poor physical function, according to a study led by Stephanie Shiau, an assistant professor in the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health.

Released: 13-Feb-2024 8:05 PM EST
Better diagnosis and treatment of cryptococcosis
University of Cologne

A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Newswise: New Trial Highlights Incremental Progress Towards a Cure for HIV-1
Released: 13-Feb-2024 9:00 AM EST
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
University of North Carolina School of Medicine

A new clinical trial, led by clinicians and researchers at the UNC School of Medicine, show that the combination of the drug vorinostat and immunotherapy may modestly shrink the latent HIV reservoir, but more work needs to be done in the field to create a cure.

Released: 5-Feb-2024 5:05 PM EST
Virus ancestry could aid bid to predict next pandemic, study finds
University of Edinburgh

Virus family history could help scientists identify which strains have potential to become the so-called Disease X that causes the next global pandemic.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Newswise: How HIV smuggles its genetic material into the cell nucleus
Released: 25-Jan-2024 11:05 AM EST
How HIV smuggles its genetic material into the cell nucleus
Max Planck Society (Max-Planck-Gesellschaft)

Around one million individuals worldwide become infected with HIV, the virus that causes AIDS, each year.

   
Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Released: 12-Jan-2024 9:05 PM EST
Nutritional acquired immunodeficiency (N-AIDS) is the leading driver of the TB pandemic
Boston University School of Medicine

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone. One in five incident TB cases were attributable to malnutrition, more than double the number attributed to HIV/AIDS.

Released: 11-Jan-2024 8:05 AM EST
Higher viral load during HIV infection can shape viral evolution
Oxford University Press

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.

Not for public release

This news release is embargoed until 8-Jan-2024 4:00 PM EST Released to reporters: 2-Jan-2024 9:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 4:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jan-2024 7:05 AM EST
Appalachia acutely suffers from opioid addiction and substance abuse disorders. An accredited online curriculum aids frontline prescribers in combating the crisis
The Rothman Orthopaedic Institute Foundation for Opioid Research Array Education

A Philadelphia-based non-profit foundation is combating the opioid addiction epidemic at the source by educating frontline allied health professionals on various aspects of the nation's opioid crisis, specifically in Pennsylvania and the Appalachian region.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       

Not for public release

This news release is embargoed until 18-Dec-2023 5:00 PM EST Released to reporters: 12-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 18-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Engaging heterosexual men more effectively could slash HIV infections in Uganda
Released: 9-Dec-2023 10:05 AM EST
Engaging heterosexual men more effectively could slash HIV infections in Uganda
Imperial College London

A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.

Released: 7-Dec-2023 11:05 AM EST
Very Early Treatment of Newborns with HIV Could Result in Medication-Free Remission for Many Babies
Ann and Robert H. Lurie Children's Hospital of Chicago

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

Released: 5-Dec-2023 7:05 AM EST
Dose matters: HIV drug could prevent coronaviruses, study finds
University of Bristol

New research by the University of Bristol has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration. The findings could strengthen the arsenal of antiviral drugs available to combat current and future coronavirus outbreaks.

Not for public release

This news release is embargoed until 1-Dec-2023 5:05 AM EST Released to reporters: 24-Nov-2023 10:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2023 5:05 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
Released: 29-Nov-2023 8:00 AM EST
Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
American Thoracic Society (ATS)

The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths in 2022. TB is also the leading cause of death among those with HIV /AIDS worldwide. In 2022, 167,000 people died of HIV-associated TB.

Released: 28-Nov-2023 12:05 PM EST
Ending the HIV Epidemic May Require Addressing “Everyday” Discrimination
Rutgers University-New Brunswick

Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 12:05 PM EST
World AIDS Day: How Far We’ve Come and Where We Still Need to Go
Rutgers University-New Brunswick

Jeffrey Kwong, a professor at the Rutgers School of Nursing and a national HIV expert discusses the progress made and the challenges to overcome in ending AIDS by 2030.

Released: 22-Nov-2023 9:05 AM EST
Fighting AIDS: Why the goal is to diagnose HIV before symptoms appear
Mayo Clinic

HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome), can hide in the body for many years before symptoms appear.

Released: 22-Nov-2023 9:05 AM EST
A luta contra a AIDS: por que é importante detectar o HIV antes que os sintomas apareçam
Mayo Clinic

O HIV (vírus da imunodeficiência humana) que causa a AIDS (síndrome de imunodeficiência adquirida) pode ficar oculto no corpo por muitos anos antes da manifestação dos sintomas.

Released: 22-Nov-2023 9:05 AM EST
La lucha contra el SIDA: por qué el objetivo es detectar el VIH antes de que aparezcan los síntomas
Mayo Clinic

El VIH (virus de la inmunodeficiencia humana), el virus que causa el SIDA (síndrome de inmunodeficiencia adquirida), se puede esconder en el organismo durante muchos años antes de que aparezcan los síntomas.

Released: 22-Nov-2023 1:05 AM EST
مكافحة مرض نقص المناعة البشري المكتسب (الإيدز): لماذا يكمن هدفنا في اكتشاف فيروس نقص المناعة البشري قبل ظهور الأعراض
Mayo Clinic

روتشستر، مينيسوتا – إن فيروس نقص المناعة البشري، الذي يسبب الإيدز (مرض نقص المناعة البشري المكتسب) بإمكانه أن يختفي في الجسم عدة سنوات قبلما تظهر الأعراض. وخلال هذا الوقت، فإنه يقضي على جزء من الجهاز المناعي دون أن نشعر. لذا فإن هدفنا هو اكتشاف فيروس نقص المناعة البشري قبلما تظهر الأعراض، مما يجعل الاختبارات الروتينية ضروريةً كي يعرف المرضى أنهم مصابون وكي يتسنى علاجهم، وهذا ما أوضحته الدكتورة ستيسي ريزا خبيرة الأمراض المُعدية والباحثة في فيروس نقص المناعة البشري لدى مايو كلينك.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise:Video Embedded what-you-need-to-know-taking-doxycycline-for-safer-sex
VIDEO
Released: 2-Nov-2023 11:05 AM EDT
What You Need to Know: Taking Doxycycline for Safer Sex
Cedars-Sinai

As the number of sexually transmitted infections (STIs) sharply rises in the U.S., new evidence suggests that a common antibiotic—doxycycline—could help prevent the spread of some bacterial infections.

Newswise: NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
Released: 2-Nov-2023 6:00 AM EDT
NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
University of California, Los Angeles (UCLA), Health Sciences

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

Newswise: Fiber, the Gut, Heart Disease and HIV
Released: 1-Nov-2023 7:05 PM EDT
Fiber, the Gut, Heart Disease and HIV
Cedars-Sinai

Investigators from Cedars-Sinai have made two important discoveries about fiber and the gut microbiome in patients with human immunodeficiency virus, or HIV.

Released: 1-Nov-2023 4:05 PM EDT
Pet ownership may contribute to health care barriers for people with HIV
University of Florida

People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.

Newswise: Integrated chronic care in Africa can improve outcomes and save money
Released: 9-Oct-2023 5:05 AM EDT
Integrated chronic care in Africa can improve outcomes and save money
La Trobe University

Across Africa about two million premature deaths each year are caused by the effects of diabetes and hypertension.

Newswise: $2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
Released: 5-Oct-2023 5:05 PM EDT
$2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
University of Texas Health Science Center at Houston

A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness.

Released: 3-Oct-2023 6:05 AM EDT
Pharmacists can improve access to life-saving vaccines
University of Waterloo

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.



close
1.48576